BackEssex Bio-Technology Limited Overview
Essex Bio-Technology Limited

Essex Bio-Technology Limited Return on Equity

Essex Bio-Technology Limited (1061.HK) has a ROE of 22.7%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

22.70%

Return on Equity

22.70%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Essex Bio-Technology Limited (1061.HK) FAQ

The latest ROE for 1061.HK is 22.7%. That is above the sector sector average of 11.3%. Investors often review this figure alongside Essex Bio-Technology Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, 1061.HK currently prints 22.7% for ROE, while the sector average sits near 11.3%. That is roughly 100.9% above the sector mean. Large gaps often invite a closer look at Essex Bio-Technology Limited's growth, margins, and balance sheet.

Return on Equity shows how effectively Essex Bio-Technology Limited converts resources into returns. At 22.7%, 1061.HK may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 1061.HK's ROE (22.7%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.